S. C. YURTAYDIN Et Al. , "Pegylated Interferon a 2a plus Tenofovir or Placebo forthe treatment of hepatitis delta First results of the HIDIT 2 study," AASLD 2012 63rd Annual Meeting of the American Association for the Study of Liver Disease , 2012
YURTAYDIN, S. C. Et Al. 2012. Pegylated Interferon a 2a plus Tenofovir or Placebo forthe treatment of hepatitis delta First results of the HIDIT 2 study. AASLD 2012 63rd Annual Meeting of the American Association for the Study of Liver Disease .
YURTAYDIN, S. C., Wedemeyer, H., Caruntu, F. A., Curescu, M. G., YALÇIN, K., AKARCA, U. S., ... GÜREL, S.(2012). Pegylated Interferon a 2a plus Tenofovir or Placebo forthe treatment of hepatitis delta First results of the HIDIT 2 study . AASLD 2012 63rd Annual Meeting of the American Association for the Study of Liver Disease
YURTAYDIN, ONUR Et Al. "Pegylated Interferon a 2a plus Tenofovir or Placebo forthe treatment of hepatitis delta First results of the HIDIT 2 study," AASLD 2012 63rd Annual Meeting of the American Association for the Study of Liver Disease, 2012
YURTAYDIN, ONUR Et Al. "Pegylated Interferon a 2a plus Tenofovir or Placebo forthe treatment of hepatitis delta First results of the HIDIT 2 study." AASLD 2012 63rd Annual Meeting of the American Association for the Study of Liver Disease , 2012
YURTAYDIN, S. C. Et Al. (2012) . "Pegylated Interferon a 2a plus Tenofovir or Placebo forthe treatment of hepatitis delta First results of the HIDIT 2 study." AASLD 2012 63rd Annual Meeting of the American Association for the Study of Liver Disease .
@conferencepaper{conferencepaper, author={ONUR KESKİN Et Al. }, title={Pegylated Interferon a 2a plus Tenofovir or Placebo forthe treatment of hepatitis delta First results of the HIDIT 2 study}, congress name={AASLD 2012 63rd Annual Meeting of the American Association for the Study of Liver Disease}, city={}, country={}, year={2012}}